Total Payments
$7,104
2024 Payments
$129.15
Companies
31
Transactions
97
Medicare Patients
1,202
Medicare Billing
$140,202
Payment Breakdown by Category
Food & Beverage$5,587 (78.6%)
Travel$1,005 (14.1%)
Other$300.00 (4.2%)
Research$117.14 (1.6%)
Education$94.80 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,587 | 89 | 78.6% |
| Travel and Lodging | $1,005 | 3 | 14.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $300.00 | 1 | 4.2% |
| Unspecified | $117.14 | 2 | 1.6% |
| Education | $94.80 | 2 | 1.3% |
Payments by Type
General
$6,987
95 transactions
Research
$117.14
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,298 | 29 | $0 (2023) |
| Olympus Corporation of the Americas | $872.40 | 5 | $0 (2017) |
| Gilead Sciences, Inc. | $605.74 | 5 | $0 (2019) |
| Boston Scientific Corporation | $370.15 | 6 | $0 (2020) |
| Apollo Endosurgery US Inc | $362.09 | 3 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $329.35 | 7 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $238.64 | 3 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $180.31 | 4 | $0 (2017) |
| QOL Medical, LLC | $167.07 | 3 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $155.74 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $129.15 | 1 | Ipsen Biopharmaceuticals, Inc ($129.15) |
| 2023 | $110.32 | 2 | ABBVIE INC. ($100.32) |
| 2022 | $329.10 | 3 | ABBVIE INC. ($300.00) |
| 2021 | $383.42 | 20 | AbbVie Inc. ($127.98) |
| 2020 | $250.16 | 4 | E.R. Squibb & Sons, L.L.C. ($119.02) |
| 2019 | $1,104 | 14 | AbbVie, Inc. ($470.80) |
| 2018 | $2,080 | 25 | AbbVie, Inc. ($615.81) |
| 2017 | $2,718 | 28 | Olympus Corporation of the Americas ($872.40) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/14/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $129.15 | General |
| Category: Rare Disease | ||||||
| 11/30/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $100.32 | General |
| Category: VIROLOGY | ||||||
| 09/13/2023 | ERBE USA Inc | Erbe VIO3 (Device) | Food and Beverage | Cash or cash equivalent | $10.00 | General |
| Category: Gastroenterology | ||||||
| 06/29/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Gastroenterology | ||||||
| 02/08/2022 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/11/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Gastroenterology | ||||||
| 10/08/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2021 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 08/26/2021 | PFIZER INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: INFLAMMATION | ||||||
| 08/25/2021 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $17.57 | General |
| Category: THERAPY FOR CSID | ||||||
| 08/04/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/22/2021 | Ironwood Pharmaceuticals, Inc | Linzess (Drug), GIVLAARI | Food and Beverage | Cash or cash equivalent | $18.56 | General |
| Category: GI | ||||||
| 07/14/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: IMMUNOLOGY | ||||||
| 06/17/2021 | Ironwood Pharmaceuticals, Inc | Linzess (Drug), GIVLAARI | Food and Beverage | Cash or cash equivalent | $13.55 | General |
| Category: GI | ||||||
| 06/16/2021 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $15.88 | General |
| Category: THERAPY FOR CSID | ||||||
| 06/02/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: IMMUNOLOGY | ||||||
| 05/05/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: IMMUNOLOGY | ||||||
| 04/28/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: IMMUNOLOGY | ||||||
| 04/05/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: IMMUNOLOGY | ||||||
| 03/22/2021 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: GI COLON PREP | ||||||
| 03/15/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/25/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/17/2021 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $68.05 | General |
| Category: Antibiotic | ||||||
| 02/10/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 489 | 767 | $178,050 | $66,101 |
| 2022 | 5 | 218 | 293 | $68,484 | $23,377 |
| 2021 | 7 | 171 | 178 | $168,207 | $17,096 |
| 2020 | 11 | 324 | 418 | $116,252 | $33,628 |
Total Patients
1,202
Total Services
1,656
Medicare Billing
$140,202
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 214 | 457 | $68,550 | $28,280 | 41.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 190 | 199 | $79,600 | $27,122 | 34.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 63 | 89 | $17,800 | $8,450 | 47.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $12,100 | $2,250 | 18.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 60 | 60 | $24,015 | $9,122 | 38.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 86 | 151 | $22,293 | $8,317 | 37.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 29 | 30 | $8,304 | $3,152 | 38.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $11,220 | $1,773 | 15.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 25 | 34 | $2,652 | $1,014 | 38.2% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 29 | 29 | $51,098 | $5,586 | 10.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 35 | 35 | $17,815 | $4,080 | 22.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 29 | $9,686 | $2,509 | 25.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 29 | 30 | $35,400 | $1,972 | 5.6% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 30 | 30 | $47,130 | $1,362 | 2.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 13 | 14 | $4,592 | $1,149 | 25.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 11 | $2,486 | $436.08 | 17.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 104 | 190 | $30,780 | $11,026 | 35.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 76 | 81 | $24,786 | $8,816 | 35.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 20 | 20 | $12,936 | $4,046 | 31.3% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 24 | 24 | $15,530 | $1,975 | 12.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 22 | 22 | $11,109 | $1,951 | 17.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $5,599 | $1,320 | 23.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 14 | $4,676 | $1,218 | 26.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 15 | 15 | $3,405 | $1,066 | 31.3% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 11 | 11 | $3,163 | $1,012 | 32.0% |
About Dr. Sahil Patel, M.D
Dr. Sahil Patel, M.D is a Gastroenterology healthcare provider based in Lebanon, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2012. The National Provider Identifier (NPI) number assigned to this provider is 1336403591.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sahil Patel, M.D has received a total of $7,104 in payments from pharmaceutical and medical device companies, with $129.15 received in 2024. These payments were reported across 97 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,587).
As a Medicare-enrolled provider, Patel has provided services to 1,202 Medicare beneficiaries, totaling 1,656 services with total Medicare billing of $140,202. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Lebanon, PA
- Active Since 07/02/2012
- Last Updated 03/07/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1336403591
Products in Payments
- Mavyret (Drug) $938.91
- EVIS EXERA (Device) $895.23
- Epclusa (Drug) $480.74
- Overstitch (Device) $362.09
- XIFAXAN (Drug) $359.39
- SKYRIZI (Biological) $300.00
- Humira (Biological) $256.46
- Kanuma (Drug) $238.64
- Sucraid (Drug) $133.62
- IQIRVO (Drug) $129.15
- STELARA (Biological) $123.12
- INJECTAFER (Drug) $122.62
- NAMZARIC (Drug) $120.85
- ELIQUIS (Drug) $119.02
- RELISTOR (Drug) $118.12
- HUMIRA (Biological) $113.17
- ORISE (Device) $108.87
- ESD - Core Endoscopy (Device) $106.54
- Talicia (Drug) $105.91
- Vascepa (Drug) $105.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lebanon
Corey Siegel, M.d, M.D
Gastroenterology — Payments: $666,177
Gastroenterology $666,177
Brian Lacy, Ph.d; M.d, PH.D; M.D
Gastroenterology — Payments: $272,238
Gastroenterology $272,238
Audrey Calderwood, Md, MD
Gastroenterology — Payments: $93,062
Gastroenterology $93,062
Dr. Shelby Sullivan, Md, MD
Gastroenterology — Payments: $66,641
Gastroenterology $66,641
Stuart Gordon, M.d, M.D
Gastroenterology — Payments: $66,131
Gastroenterology $66,131
Dr. Michael Winter, Md, MD
Gastroenterology — Payments: $54,448
Gastroenterology $54,448